Acid sphingomyelinase inhibition improves motor behavioral deficits and neuronal loss in an amyotrophic lateral sclerosis mouse model

키워드

참고문헌 (33)

1. Rowland LP, "Amyotrophic lateral sclerosis", New Engl J Med, 344, pp.1688~1700 (2001)
2. Chio A, "Prognostic factors in ALS : a critical review", Amyotroph Lateral Scler, 10, pp.310~323 (2009)
3. Hardiman O, "Amyotrophic lateral sclerosis", Nat Rev Dis Primers, 3, pp.17071~ (2017)
4. Zou ZY, "Genetic epidemiology of amyotrophic lateral sclerosis : a systematic review and meta-analysis", J Neurol Neurosurg Psychiatr, 88, pp.540~549 (2017)
5. Boylan K, "Familial ALS", Neurol Clin, 33, pp.807~830 (2015)
6. Mejzini R, "ALS genetics, mechanisms, and therapeutics : where are we now?", Front Neurosci, 13, pp.1310~ (2019)
7. Kim G, "ALS genetics : gains, losses, and implications for future therapies", Neuron, 108, pp.822~842 (2020)
8. Vance C, "Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6", Science, 323, pp.1208~1211 (2009)
9. Rosen DR, "Mutations in Cu", Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, 1993, pp.362, 59~
10. Oakes JA, "TBK1 : a new player in ALS linking autophagy and neuroinflammation", Mol Brain, 10, pp.5~ (2017)
11. Sreedharan J, "TDP-43mutations in familial and sporadic amyotrophic lateral sclerosis", Science, 319, pp.1668~1672 (2008)
12. Renton AE, "A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD", Neuron, 72, pp.257~268 (2011)
13. Schissel SL, "Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene", J Biol Chem, 271, pp.18431~18436 (1996)
14. Kornhuber J, "Secretory sphingomyelinase in health and disease", Biol Chem, 396, pp.707~736 (2015)
15. Lee JK, "Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer’s disease", J Exp Med, 211, pp.1551~1570 (2014)
16. Ong WY, "Role of sphingomyelinases in neurological disorders", Expert Opin Ther Targets, 19, pp.1725~1742 (2015)
17. Min Hee Park, "Potential therapeutic target for aging and age-related neurodegenerative diseases: the role of acid sphingomyelinase", Experimental and Molecular Medicine, 52, pp.1~10 (2020), 생화학분자생물학회[DOI]
18. Jenkins RW, "Roles and regulation of secretory and lysosomal acid sphingomyelinase", Cell Signal, 21, pp.836~846 (2009)
19. Xiang Li, "Oxidative stress triggers Ca-dependent lysosome trafficking and activation of acid sphingomyelinase", Cell Physiol Biochem, 30, pp.815~826 (2012)
20. Smith EL, "The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases", FASEB J, 22, pp.3419~3431 (2008)
21. Park MH, "Vascular and neurogenic rejuvenation in aging mice by modulation of ASM", Neuron, 100, pp.167~182 (2018)
22. Qiu H, "ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects", J Clin Invest, 124, pp.981~999 (2014)
23. Mitchell JC, "Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age-and dose-dependent fashion", Acta Neuropathol, 125, pp.273~288 (2013)
24. Sharma A, "ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function", Nat Commun, 7, pp.10465~ (2016)
25. Hewitt C, "Novel FUS", TLS mutations and pathology in familial and sporadic amyotrophic lateral sclerosis, 2010, pp.67, 455~461
26. Cutler RG, "Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis", Ann Neurol, 52, pp.448~457 (2002)
27. Arenas A, "FUS regulates autophagy by mediating the transcription of genes critical to the autophagosome formation", J Neurochem, 157, pp.752~763 (2021)
28. Baskoylu SN, "Disrupted autophagy and neuronal dysfunction in C. elegans knockin models of FUS amyotrophic lateral sclerosis", Cell Rep, 38, pp.110195~ (2022)
29. Petrov D, "ALS clinical trials review : 20 years of failure. Are we any closer to registering a new treatment?", Front Aging Neurosci, 9, pp.68~ (2017)
30. Kornhuber J, "Functional Inhibitors of Acid Sphingomyelinase(FIASMAs) : a novel pharmacological group of drugs with broad clinical applications", Cell Physiol Biochem, 26, pp.9~20 (2010)
31. Park MH, "Discovery of a dual-action small molecule that improves neuropathological features of Alzheimer’s disease mice", Proc Natl Acad Sci U S A, 119, pp.e2115082119~ (2022)
32. Horinouchi K, "Acid sphingomyelinase deficient mice : a model of types A and B Niemann-Pick disease", Nat Genet, 10, pp.288~293 (1995)
33. Shiihashi G, "Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice", Brain, 139, pp.2380~2394 (2016)

관련 논문AI추천